Belay Diagnostics names Stanford neuro-oncologist Seema Nagpal, MD, its first chief medical officer
Nagpal's experience treating patients with CNS cancers will help shape Belay's clinical strategy and expand the use of CSF liquid biopsy testing CHICAGO, Nov. 10, 2026 /PRNewswire/ -- Belay Diagnostics today announced that Seema Nagpal, MD, a practicing Stanford neuro-oncologist, will...
Covered in this story
Call it yourself
No calls on $CNS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cohen & Steers Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.